Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens - Wikidata - wikimedia - TriplyDB

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

http://www.wikidata.org/entity/Q24799351

about

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.

P2860

Q24610970-B440E882-8830-4C08-851B-945381B3FE34 Q37692734-8362DFC3-D670-4AA5-AD8E-A4A215AE47AE

P2860

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

http://www.wikidata.org/entity/Q24799351

description

2005 nî lūn-bûn

@nan

2005 թուականին հրատարակուած գիտական յօդուած

@hyw

2005 թվականին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@ast

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@en

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@nl

type

label

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@ast

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@en

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@nl

prefLabel

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@ast

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@en

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@nl

P1433

Q24799351-42C0FA4A-B3E2-4BB5-98FF-45A3967C82BA

P1476

Q24799351-8666D331-4A12-4AE5-92D3-797E0A24241B

P2093

Q24799351-1CFF9E10-5C36-409B-92C5-B379FD2B0207

Q24799351-58898A96-0DE2-48B4-B8E8-CDBE58419F6D

Q24799351-9D3AD31D-6A68-4174-AFB0-1D5920A872FF

Q24799351-9E9DF432-47F1-4167-A8F6-2C51E81EADC5

Q24799351-B815E7BE-DDE9-4789-89FE-C10CCB7701C1

Q24799351-CE8AC9A9-2C2F-41E8-BC5D-AD52B28BDF16

Q24799351-E041B0A0-96C2-4F84-A88B-12DFB9649170

Q24799351-F2CB1793-DF94-42D1-A36F-51F1927352BC

P2860

Q24799351-22A04AF3-CC90-472B-B225-CCDB87C10F93

Q24799351-367B92ED-1467-4E1C-AFCA-268E400C7B90

Q24799351-3ED536D8-727D-4417-8C43-3E0C14B537F7

Q24799351-4EC8F1BC-2143-4F9D-95D9-9745010D2FC5

Q24799351-5040C7B2-7078-45AD-9EA2-428F93D3C808

Q24799351-5084B82A-042D-4CCC-8710-F7EBC76C66B7

Q24799351-5BB45CDC-828E-4AE7-9168-5332B309C813

Q24799351-655F64FA-42E8-4B19-9AD8-B2DBEC85C052

Q24799351-6824C5AE-D60B-4D4F-86AC-957D18788A7A

Q24799351-78C86480-309A-45B8-924B-BF5F43531971

P2888

Q24799351-816FF7FB-B91E-4F70-A88A-995B048BA9D5

P304

Q24799351-6EFC7E44-86D0-4CC6-B85E-E688B6F15958

P31

Q24799351-ACDBBF63-B1A9-4D12-B680-C82D01E16129

P356

Q24799351-63D083E2-72E9-4E60-BA93-BCBCD2CAE9A8

P407

Q24799351-B51A1AE0-E354-4D73-B1C7-2FB575372ECC

P433

Q24799351-7149D098-2196-48DC-9318-15F647A68B5F

P478

Q24799351-2BCC59DF-7B01-4339-8360-3DE27BF20F57

P50

Q24799351-6FBFEDDE-5A98-414C-A8E0-B2D74CC60CC1

P577

Q24799351-483A1951-7FA6-4953-B629-9995DD6D2102

P5875

Q24799351-8003B54E-815D-4E96-986D-4038C6BE85F8

P6179

Q24799351-2F6BDFB4-BF84-444E-90D3-54F124E4EC06

P698

Q24799351-D1432D44-0330-4A4A-85E1-6918063DA867

P932

Q24799351-A635EC5A-12A4-4EF7-965D-E0ED14A1292C

P356

P1433

BMC Infectious Diseases

P1476

Abacavir, efavirenz, didanosin ...... inhibitor-containing regimens

@en

P2093

Bonnie F Pobiner

http://www.w3.org/2001/XMLSchema#string

Calvin J Cohen

http://www.w3.org/2001/XMLSchema#string

Daniel S Berger

http://www.w3.org/2001/XMLSchema#string

Gary E Pakes

http://www.w3.org/2001/XMLSchema#string

Jaime E Hernandez

http://www.w3.org/2001/XMLSchema#string

Jerry W Snidow

http://www.w3.org/2001/XMLSchema#string

Karen T Tashima

http://www.w3.org/2001/XMLSchema#string

Qiming Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of ribonucleotide reductase by 2'-substituted deoxycytidine analogs: possible application in AIDS treatment

Hydroxyurea to inhibit human immunodeficiency virus-1 replication.

Hydroxyurea in the treatment of HIV-1.

Abacavir: a review of its clinical potential in patients with HIV infection.

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.

Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort.

Direct analysis of mitochondrial toxicity of antiretroviral drugs.

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

P2888

P304

23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-5-23

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Susan Swindells

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7916751

http://www.w3.org/2001/XMLSchema#string

P6179

1032594510

http://www.w3.org/2001/XMLSchema#string

P698

15819974

http://www.w3.org/2001/XMLSchema#string

P932

1090576

http://www.w3.org/2001/XMLSchema#string